Clinical Trial Update: A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of Interleukin-12 in patients with Acute Myeloid Leukemia, which is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING